Chinese wholesale Covid-19 Neutralization Ab - KaiBiLi COVID-19 Antigen – Genesis
Chinese wholesale Covid-19 Neutralization Ab - KaiBiLi COVID-19 Antigen – Genesis Detail:
Introduction
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.
This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE).
Detection
The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.
Specimen
Nasal or nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 140 TCID50/mL
ACCURACY （Nasal swab）
Positive Percent Agreement: 96.6%
Negative Percent Agreement:100%
Overall Percent Agreement: 98.9%
ACCURACY(Nasopharyngeal swab）
Positive Percent Agreement: 97.0%
Negative Percent Agreement:98.3%
Overall Percent Agreement: 97.7%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
|
Description |
Qty |
| COVID-19 antigen test devices |
20 |
| Sterilized swabs |
20 |
| Extraction tubes (with 0.5mL extraction buffer) |
20 |
| Nozzles with filter |
20 |
| Tube Stand |
1 |
| Package Insert |
1 |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
KaiBiLiTM COVID-19 Antigen |
P211139 |
20 Tests |
Product detail pictures:
Related Product Guide:
"Sincerity, Innovation, Rigorousness, and Efficiency" is the persistent conception of our company for the long-term to develop together with customers for mutual reciprocity and mutual benefit for Chinese wholesale Covid-19 Neutralization Ab - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Zambia, Tanzania, India, Our products are mainly exported to Southeast Asia, the Middle East, North America and Europe. Our quality is surely guaranteed. If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.
By Rosalind from Suriname - 2017.05.21 12:31
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
By April from Mexico - 2017.08.28 16:02
